Investigating oral dysplasia and cancer risk using a new diagnostic tool
Oral Dysplasia and Oral Cavity Cancer Risk in Dental and Medical Surveillance Settings Using a Chairside Chip-Based Cytopathology Tool
['FUNDING_R01'] · NEW YORK UNIVERSITY · NIH-11035065
This study is testing a new, easy-to-use tool that helps doctors quickly and safely check for early signs of mouth cancer in patients who have had oral cancer or certain mouth conditions, with the hope of catching problems sooner and improving treatment outcomes.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | NEW YORK UNIVERSITY (nih funded) |
| Locations | 1 site (NEW YORK, UNITED STATES) |
| Trial ID | NIH-11035065 on ClinicalTrials.gov |
What this research studies
This research focuses on improving the diagnosis and monitoring of oral dysplasia and oral cavity cancers through a novel chairside cytopathology tool. By utilizing advanced microfluidics and artificial intelligence, the study aims to provide a non-invasive method for detecting potentially malignant oral lesions. Patients with a history of oral squamous cell carcinoma or those diagnosed with oral epithelial dysplasia will be monitored to assess the effectiveness of this new diagnostic approach. The goal is to enhance clinical surveillance and improve patient outcomes through timely and accurate diagnosis.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with a history of oral squamous cell carcinoma or those diagnosed with oral epithelial dysplasia.
Not a fit: Patients without a history of oral lesions or those not at risk for oral cavity cancers may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier detection and better management of oral cancers, significantly improving patient survival rates.
How similar studies have performed: Other research has shown promise in using advanced diagnostic tools for cancer detection, indicating potential success for this novel approach.
Where this research is happening
NEW YORK, UNITED STATES
- NEW YORK UNIVERSITY — NEW YORK, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: MCDEVITT, JOHN T — NEW YORK UNIVERSITY
- Study coordinator: MCDEVITT, JOHN T
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.